Bioworld Financial Watch articles from September 2007

Bioworld Financial Watch archives from September 2007

Nastech's 'singular' flu effort helps keep RNAi space busy.(Others Still Entering The Field)
September 3, 2007... Alnylam Pharmaceuticals Inc. is hot - but that's old news, and a cooling trend might be ahead, at least for a while. The RNAi leader's stock has appreciated a 119 percent over the past year, thanks to upbeat news flow and a steadily deeper...

Collaborations between Biotechnology Companies and Government/Nonprofit Institutions: June 1 - Aug. 30, 2007.
September 3, 2007... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: June 1-Aug. 30, 2007 Company* University/ Type Of (Country; Nonprofit@ Agreement Symbol) Abraxis ...

BioWorld stock report for Public Biotechnology Companies.
September 3, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 8/24 8/31 WK YTD (000) Aastrom Biosci ASTM 1.1 1.11 ...

Handy Aradigm inhaler key to PAH prostacyclin usage?(United Therapeutics' Remodulin Deal)
September 10, 2007... Last week's new deal between Aradigm Corp. and existing partner United Therapeutics Corp. - through its wholly owned subsidiary Lung Rx Inc. - to develop Remodulin (treprostinil) using the former's AERx Essence approach could provide the needed...

Public financing of Biotechnology: August 2007.
September 10, 2007... Public Financing Of Biotechnology: August 2007 1. COMMENCED TRADING IN AUGUST Company (Symbol) # Date Date Shares/ Price Shares Filed Comm. Units (M) Out (M) @ INITIAL OFFERINGS ...

Other financings of Public Biotechnology Companies: August 2007.
September 10, 2007... Other Financings Of Public Biotechnology Companies: August 2007 Company Type Of Number Of Amount (Symbol) # Financing Shares, Raised (M) Units Or ...

Venture Capital and other investments in Private Biotechnology Companies: August 2007.
September 10, 2007... Venture Capital And Other Investments In Private Biotechnology Companies: August 2007 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $478.41M Company Location Date Amt. (M) Adnexus Therapeutics ...

Milestone payments from corporate partners: August 2007.
September 10, 2007... Milestone Payments From Corporate Partners: August 2007 Company (Symbol) Partner (Country) Amt. Triggering #* (M) Event Ardea Valeant $0.5 Milestone Biosciences...

Money raised by Biotech in 2007: January-August.
September 10, 2007... Money Raised By Biotech In 2007: January-August Type of financing Jan. Feb. March April May Public offerings 573.50 655.36 174.05 559.13 1,257.45 Private biotechs 518.65 763.50 798.67 ...

BioWorld Stock Indicator 2007, Nasdaq Biotech Index 2007.
September 10, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. [GRAPHIC OMITTED] The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and...

BioWorld stock report for Public Biotechnology Companies.
September 10, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 8/31 9/7 WK YTD (000) Aastrom Biosci ASTM 1.11 1.14 ...

ImClone, Amgen headlines turn eyes to cancer drugs.(FDA Kidney Panel Votes On ESAs)
September 17, 2007... Topping last week's news: Outcomes for ImClone Systems Inc. with its Erbitux for cancer, and Amgen Inc.'s ambivalently received results from an FDA panel meeting related to anemia products, also widely used not only in the oncology setting but...

Protecting biotech patents is focus of audio conference.(Conference news)
September 17, 2007... A new audio conference sponsored by BioWorld Today offers biotechnology companies tools and techniques for protecting their patent portfolios. "Building and Maintaining BioPharma Patent Portfolios After KSR v. Teleflex: Strategies Addressing...

Clinical trials update: August 2007.
September 17, 2007... Clinical Trials Update: August 2007 Company * Product Description (Country; Symbol) AUTOIMMUNE Immunomedics Inc. Epratuzumab A humanized monoclonal (IMMU) antibody that...

Non-U.S. clinical trials and regulatory actions: August 2007.
September 17, 2007... Non-U.S. Clinical Trials And Regulatory Actions: August 2007 Company * Product Description (Country; Symbol) AUTOIMMUNE Astion Pharma A/S ASF-1096 An R-enantiomer of * (Denmark) ...

FDA submissions, approvals and other actions: August 2007.
September 17, 2007... FDA Submissions, Approvals And Other Actions: August 2007. Company * Product Description (Country; Symbol) AUTOIMMUNE Biogen Idec Inc. Tysabri Natalizumab (BIIB) and Elan (FDA-approved)...

BioWorld stock report for Public Biotechnology Companies.
September 17, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 9/7 9/14 WK YTD (000) Aastrom Biosci ASTM 1.14...

Microbia's IBS drug: taking the place of Risky Zelnorm?(Potential $330M Deal With Forest)
September 24, 2007... Coming up with drugs that belong on the radar--and prescription pads--of primary-care doctors is "a challenge that biotech is treading carefully on," as Peter Hecht, CEO of Microbia Inc., told BioWorld Financial Watch last week, but Hecht's...

U.S. public offering performance by underwriter: January 1 - August 31, 2007.
September 24, 2007... Underwriter Biotechnology Company Date Offering 9/14/07 priced price per Share share ** Price AG Edwards ...

BioWorld stock report for Public Biotechnology Companies.
September 24, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 9/14 9/21 WK YTD (000) Aastrom Biosci ASTM 1.11...